PDCD1 and neoplasm: Using gene expression profiling, Ng et al. found higher PD‐L1 expression on tumor and non‐tumor cells in nodal EBV+ CTL cases than in ENKTL, suggesting potential therapeutic implications for anti‐PD‐1 treatment in nodal EBV+ CTL.33